Incidence of esophageal adenocarcinoma increasing dramatically worldwide
Esophageal adenocarcinoma has become more prevalent during the past several decades, with the onset and magnitude of this increase varying even between neighboring countries and states, according to recent results.
Researchers evaluated data on 117,946 incident cases of esophageal adenocarcinoma collected from cancer registries in North America, Europe, Australia and Asia. Incorporated information was dated from 1955 through 2009 and included the number of diagnosed cancers per calendar year, within age groups at 5-year increments and according to sex. Ninety-nine percent of cases occurred in patients aged 40 years or older, and 22.3% occurred in women.
Overall, the age-adjusted incidence rates of esophageal adenocarcinoma increased during the study period. The annual proportional increase ranged from 3.5% observed in Scotland to 8.1% in Hawaii, and joinpoint analyses performed for evaluable registries indicated potential starting points for the increase ranging from 1976 in Denmark (average change per decade=0.26 per 100,000 person-years before joinpoint, 0.61 after, P<.05) to 1991 in Sweden (0.12 per 100,000 person-years before joinpoint, 0.74 after, P<.0001).
In most cases, the rate increase was proportionally similar between men and women, but men developed the illness three to six times more frequently overall, with rates seven to nine times greater among men than women in the US, specifically.
Incidence rates in men typically mimicked one of the following calendar period patterns:
- An initial phase with a steady rate of one or less cases per 100,000 person-years, followed by a second phase with a monotonic increase by one to two cases per 100,000 person-years per decade
- A continuous increase of roughly two to three cases per 100,000 person-years per decade throughout the evaluated period
Cases among women were less frequent and more prone to random fluctuations, but followed a largely similar pattern. Investigators also noted that, with one exception, the data series for areas fitting the second pattern began with incidence rates at or above those reported during the initial phases of the areas fitting the first pattern.
“While changes in the exposure prevalence to known major risk factors and mis- or reclassification of other malignancies in the esophagus and proximal part of the stomach have likely contributed to an increasing incidence of esophageal adenocarcinoma, they are unlikely to explain neither the abrupt change nor the astounding rate of increase,” the researchers wrote. “Therefore, it seems reasonable to hypothesize that effects of a strong, highly prevalent and yet unidentified causal factor … are superimposed on the effects of known risk factors. The obvious variation in time of onset of the epidemic and the uneven distribution among sexes may provide important clues as to the nature of this exposure.”